Skip to main content

Advertisement

Log in

Lack of association between interleukin-22 gene polymorphisms and cancer risk: a case–control study and a meta-analysis

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

Interleukin-22 (IL22) has been implicated in inflammation and tumorigenesis. The association between IL22 gene polymorphisms and cancer risk has been widely explored. However, the limited sample sizes of previous studies may produce inadequate statistical power and conflicting results, which calls for further investigations. In this study, we recruited a total of 1490 cancer patients (480 liver cancer patients, 550 lung cancer patients, and 460 gastric cancer patients) and 800 normal controls to explore the associations between IL22 gene polymorphisms (rs1179251, rs2227485, rs2227511, and rs2227473) and cancer risk.

Method

The genotyping was performed with polymerase chain reaction–restriction fragment length polymorphism (PCR–RFLP) and Sanger sequencing.

Results

Our results showed that none of the four IL22 gene polymorphisms was associated with the risk of liver, lung or gastric cancer in Hubei Han Chinese population. To improve the statistical strength, a meta-analysis was further conducted. The results further confirmed our present findings and showed that rs1179251, rs2227485, and rs2227473 were not associated with cancer risk in total or stratified analysis.

Conclusion

Consequently, the rs1179251, rs2227485, rs2227511, and rs2227473 polymorphisms may not be associated with cancer risk. However, further investigations using larger samples in different ethnic populations are required.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Lim C, Savan R (2014) The role of the IL-22/IL-22R1 axis in cancer. Cytokine Growth Factor Rev 25(3):257–271. https://doi.org/10.1016/j.cytogfr.2014.04.005

    Article  PubMed  CAS  Google Scholar 

  2. Wolk K, Sabat R (2006) Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev 17(5):367–380. https://doi.org/10.1016/j.cytogfr.2006.09.001

    Article  PubMed  CAS  Google Scholar 

  3. Sabat R, Ouyang W, Wolk K (2014) Therapeutic opportunities of the IL-22-IL-22R1 system. Nat Rev Drug Discov 13(1):21–38. https://doi.org/10.1038/nrd4176

    Article  PubMed  CAS  Google Scholar 

  4. Wolk K, Witte E, Witte K et al (2010) Biology of interleukin-22. Semin Immunopathol 32(1):17–31. https://doi.org/10.1007/s00281-009-0188-x

    Article  PubMed  CAS  Google Scholar 

  5. Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492

    Article  PubMed  Google Scholar 

  6. Zhang M, Tuo J, Li GC (2013) Wei SZ (2018) Cancer incidence and mortality in Hubei cancer registries. Cancer Res Prev Treat 45(06):414–419. https://doi.org/10.3971/j.issn.1000-8578.2018.17.1200

    Article  CAS  Google Scholar 

  7. Cardon LR, Bell JI (2001) Association study designs for complex diseases. Nat Rev Genet 2(2):91–99. https://doi.org/10.1038/35052543

    Article  PubMed  CAS  Google Scholar 

  8. Shastry BS (2009) SNPs: impact on gene function and phenotype. Methods Mol Biol 578:3–22. https://doi.org/10.1007/978-1-60327-411-1_1

    Article  PubMed  CAS  Google Scholar 

  9. Qin SY, Yang XW, Luo W et al (2015) Association of interleukin 22 polymorphisms with gastric cancer risk. Tumour Biol 36(3):2033–2039. https://doi.org/10.1007/s13277-014-2810-3

    Article  PubMed  CAS  Google Scholar 

  10. He X, Wang XH, Qiu ZG et al (2013) A study on the correlation between single nucleotide polymorphism (SNP) of IL-22 gene and susceptibility to HCC. J Gannan Med Univ 33(1):29–32

    CAS  Google Scholar 

  11. Wang YM, Li ZX, Tang FB et al (2016) Association of genetic polymorphisms of interleukins with gastric cancer and precancerous gastric lesions in a high-risk Chinese population. Tumour Biol 37(2):2233–2242. https://doi.org/10.1007/s13277-015-4022-x

    Article  PubMed  CAS  Google Scholar 

  12. Thompson CL, Plummer SJ, Tucker TC et al (2010) Interleukin-22 genetic polymorphisms and risk of colon cancer. Cancer Causes Control 21(8):1165–1170. https://doi.org/10.1007/s10552-010-9542-5

    Article  PubMed  Google Scholar 

  13. Mohebbi SR, Karimi K, Rostami F et al (2014) Association of interleukin-22 gene polymorphism (rs1179251) and colorectal cancer risk in the Iranian population. Indian J Virol 22(1):29–36. https://doi.org/10.1007/s13337-011-0029-0

    Article  Google Scholar 

  14. Zhao T, Wu X, Liu J (2015) Association between interleukin-22 genetic polymorphisms and bladder cancer risk. Clinics (Sao Paulo) 70(10):686–690. https://doi.org/10.6061/clinics/2015(10)05

    Article  Google Scholar 

  15. Liao F, Hsu YC, Kuo SH et al (2014) Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphoma. Blood Cancer J 4:e20. https://doi.org/10.1038/bcj.2014.70

    Article  Google Scholar 

  16. Eun YG, Shin IH, Lee YC et al (2013) Interleukin 22 polymorphisms and papillary thyroid cancer. J Endocrinol Invest 36(8):584–587. https://doi.org/10.3275/8879

    Article  PubMed  CAS  Google Scholar 

  17. Zhang G, Chen X, Chan L et al (2011) An SNP selection strategy identified IL-22 associating with susceptibility to tuberculosis in Chinese. Sci Rep 1:20. https://doi.org/10.1038/srep00020

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Munafò MR, Flint J (2004) Meta-analysis of genetic association studies. Trends Genet 20(9):439–444. https://doi.org/10.1016/j.tig.2004.06.014

    Article  PubMed  CAS  Google Scholar 

  19. Chen BF, Yi C, Wang JD et al (2019) A comprehensive study of CD44 rs 187115 variant and cancer risk in a central Chinese population. J Cell Biochem 120(8):12949–12957. https://doi.org/10.1002/jcb.28566

    Article  PubMed  CAS  Google Scholar 

  20. Sedgwick P (2012) Multiple significance tests: the Bonferroni correction. BMJ 344:e509. https://doi.org/10.1136/bmj.e509

    Article  Google Scholar 

  21. Hayashino Y, Noguchi Y, Fukui T (2005) Systematic evaluation and comparison of statistical tests for publication bias. J Epidemiol 15(6):235–243

    Article  PubMed  PubMed Central  Google Scholar 

  22. Cargill M, Altshuler D, Ireland J et al (1999) Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 22(3):231–238. https://doi.org/10.1038/10290

    Article  PubMed  CAS  Google Scholar 

  23. Lek M, Karczewski KJ, Minikel EV et al (2016) Analysis of protein-coding genetic variation in 60,706 humans. Nature 536(7616):285–291. https://doi.org/10.1038/nature19057

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Zeng Y, Wang G, Yang E et al (2015) Aberrant gene expression in humans. PLoS Genet 11(1):e1004942. https://doi.org/10.1371/journal.pgen.1004942

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. Zhang J, Zhao T, Xu C et al (2018) Four polymorphisms in the IL-22 gene and the risk of cancer: a meta-analysis. J Evid Based Med 11(2):101–104. https://doi.org/10.1111/jebm.12296

    Article  PubMed  Google Scholar 

  26. Lin L, Xu W, Zhang G et al (2017) Association of interleukin-22 polymorphisms with the colon cancer: a case-control study. Immunol Lett 188:59–63. https://doi.org/10.1016/j.imlet.2017.06.007

    Article  PubMed  CAS  Google Scholar 

  27. Hamed A, Gholamreza A, Ahmad J et al (2018) Atorvastatin, losartan and captopril may upregulate IL-22 in hypertension and coronary artery disease. Life Sci 207:525–531. https://doi.org/10.1016/j.lfs.2018.07.005

    Article  CAS  Google Scholar 

  28. Ding GG, Zhang GL, Chen XC et al (2012) A study on the relationship between single nucleotide polymorphisms of interleukin-22 and susceptibility to pulmonary tuberculosis. Chin J Tuberc Respir Dis 35(8):596–600

    Google Scholar 

Download references

Funding

This work was supported by grants from the National Natural Science Foundation of China (81502427), the Natural Science Foundation of Hubei Province (2019CFB756), and the Fundamental Research Funds for the Central Universities (WUT: 2018IB023, 2019IB005 and 2019-HS-B1-13).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bifeng Chen.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, H., Huang, C., Liu, Y. et al. Lack of association between interleukin-22 gene polymorphisms and cancer risk: a case–control study and a meta-analysis. Int J Clin Oncol 25, 521–530 (2020). https://doi.org/10.1007/s10147-019-01595-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-019-01595-8

Keywords

Navigation